Davis Polk advised Goldman, Sachs & Co. and Citigroup as joint book-running managers in connection with the $55 million initial public offering of common stock by Atara Biotherapeutics, Inc. Atara Biotherapeutics’ common stock is listed on the NASDAQ Global Select Market under the symbol “ATRA.” 

Based in Brisbane, California, Atara Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle-wasting conditions and oncology.  

Simpson Thacher recently represented J.P. Morgan Securities LLC, as solicitation agent, in connection with SEC-registered consent solicitations and offers to guarantee by Whiting Petroleum Corporation (“Whiting”) to the holders of the 8.125% Senior Notes due 2019, 5.5% Senior Notes due 2021 and 5.5% Senior Notes due 2022 issued by Kodiak Oil & Gas Corp.

Simpson Thacher recently represented the underwriters led by Deutsche Bank Securities Inc., Barclays Capital Inc. and Credit Suisse Securities (USA) LLC (the “underwriters”)  in connection with the offering by Trina Solar Limited (“Trina Solar”) of US$115.0 million principal amount of 4.0% Convertible Senior Notes due 2019 (the “Notes”) pursuant to Rule 144A and Regulation S, which included the exercise in full of the option to purchase an additional US$15.0 million principal amount of the Notes granted by Trina Solar.

Paul Hastings LLP represented the banks in financing the acquisition of The Sleep Train, Inc. and its subsidiaries by Mattress Firm, a leading specialty retailer of mattresses and related products and accessories in the United States with over 1,500 stores in over 36 states.
 
Paul Hastings LLP represented Barclays Bank PLC as administrative agent and Barclays Bank PLC and other banks as joint lead arrangers and joint bookrunners in connection with a $720 million term loan credit facility and a $125 million asset-based revolving credit facility for Mattress Firm.

Davis Polk advised the joint lead managers on an English law Regulation S-only offering by ENN Energy Holdings Limited of its US$400 million 3.25% bonds due 2019. The joint lead managers are UBS AG, Hong Kong Branch and The Hongkong and Shanghai Banking Corporation.  

Davis Polk is advising Merrill Lynch, Pierce, Fenner & Smith Incorporated as sole lead arranger and sole bookrunner of a $5 billion senior unsecured bridge term loan facility for Southwestern Energy Company, in connection with its agreement to acquire certain oil and gas properties and related assets from Chesapeake Appalachia, L.L.C.

Ashurst advised Oriel Securities as the bookrunners and sponsors on a follow on fundraising for Foresight Solar Fund ("Foresight" or the "Company"), the UK-based closed-ended investment company which listed on the LSE last year. The company raised £60.1 million in gross proceeds via an initial placing and offer for subscription on the London Stock Exchange's Main Market and has also created a placing programme of further shares over the next year.

Davis Polk advised Bank of America, N.A. as administrative agent and Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and KeyBanc Capital Markets Inc. as joint lead arrangers and joint bookrunners in connection with commitments for a $1.6 billion senior unsecured bridge loan facility provided to STERIS Corporation in connection with its proposed $1.9 billion acquisition of Synergy Health plc.

Davis Polk advised Citigroup Global Markets Inc. as sole lead arranger of a $1.75 billion senior unsecured bridge loan facility and as joint lead arranger of a $1 billion senior unsecured term loan facility for Eastman Chemical Company in connection with Eastman Chemical’s acquisition of Taminco Corporation.

Davis Polk advised Merrill Lynch, Pierce, Fenner & Smith Incorporated, HSBC Securities (USA), Inc. and RBC Capital Markets as joint lead arrangers and joint bookrunners and Bank of America, N.A. as administrative agent in connection with an approximately $187.5 million senior secured term loan and a $187.5 million senior secured revolving credit facility provided to Nu Skin Enterprises, Inc.